Non-motor symptoms of PD are often equally as debilitating and include cognitive dysfunction and neurological defects [6]
GLP-1 & SGLT2 Inhibitor Combination Therapy Combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors represents an advanced treatment strategy for type 2 diabetes mellitus, utilising two distinct drug classes with complementary mechanisms of action
In most people, the body produces enough carnitine
Do not discontinue GLP-1 therapy without medical guidance unless youre experiencing a serious adverse reaction, as sudden discontinuation can affect blood sugar management in patients with diabetes
Therefore, the needle must be disposed of as clinical waste while the metal and plastic components might be recycled
Balakrishnan S, Dhavamani S, Prahalathan C (2020) -cell specific transcription factors in the context of diabetes mellitus and -cell regeneration